Quarterly report pursuant to Section 13 or 15(d)

Note 5 - Commitments and Contingencies - Option Activity (Details)

v3.20.2
Note 5 - Commitments and Contingencies - Option Activity (Details)
9 Months Ended
Sep. 30, 2020
USD ($)
$ / shares
shares
Exchanged for common stock (in shares) (3,000,000)
Granted, Shares (in shares) 1,500,000
Granted, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 0.057
Share-based Payment Arrangement, Option [Member]  
Outstanding, Shares (in shares) 21,716,557
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 0.076
Outstanding, Weighted Average Remaining Life (Year)
Expired, Shares (in shares) (4,383)
Expired, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 52.50
Exchanged for common stock (in shares) (3,000,000)
Exchanged for common stock, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 0.041
Outstanding, Shares (in shares) 20,212,174
Outstanding, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 0.068
Outstanding, Weighted Average Remaining Life in Years (Year) 3 years 346 days
Outstanding, Aggregate intrinsic value | $
Exercisable, Shares (in shares) 19,212,174
Exercisable, Weighted Average Exercise Price (in dollars per share) | $ / shares $ 0.068
Exercisable, Weighted Average Remaining Life (Year) 3 years 328 days
Exercisable, Aggregate intrinsic value | $